391 related articles for article (PubMed ID: 21396500)
1. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes.
Harman SM; Vittinghoff E; Brinton EA; Budoff MJ; Cedars MI; Lobo RA; Merriam GR; Miller VM; Naftolin F; Pal L; Santoro N; Taylor HS; Black DM
Am J Med; 2011 Mar; 124(3):199-205. PubMed ID: 21396500
[TBL] [Abstract][Full Text] [Related]
2. Changing concepts: Menopausal hormone therapy and breast cancer.
Chlebowski RT; Anderson GL
J Natl Cancer Inst; 2012 Apr; 104(7):517-27. PubMed ID: 22427684
[TBL] [Abstract][Full Text] [Related]
3. Lessons learned from the Women's Health Initiative trials of menopausal hormone therapy.
Rossouw JE; Manson JE; Kaunitz AM; Anderson GL
Obstet Gynecol; 2013 Jan; 121(1):172-6. PubMed ID: 23262943
[TBL] [Abstract][Full Text] [Related]
4. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study.
Chlebowski RT; Manson JE; Anderson GL; Cauley JA; Aragaki AK; Stefanick ML; Lane DS; Johnson KC; Wactawski-Wende J; Chen C; Qi L; Yasmeen S; Newcomb PA; Prentice RL
J Natl Cancer Inst; 2013 Apr; 105(8):526-35. PubMed ID: 23543779
[TBL] [Abstract][Full Text] [Related]
5. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
6. The Women's Health Initiative randomized trials of menopausal hormone therapy and breast cancer: findings in context.
Chlebowski RT; Aragaki AK
Menopause; 2023 Apr; 30(4):454-461. PubMed ID: 36727752
[TBL] [Abstract][Full Text] [Related]
7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON MENOPAUSE-2017 UPDATE.
Cobin RH; Goodman NF;
Endocr Pract; 2017 Jul; 23(7):869-880. PubMed ID: 28703650
[TBL] [Abstract][Full Text] [Related]
8. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
[TBL] [Abstract][Full Text] [Related]
9. Is the WHI relevant to HRT started in the perimenopause?
Harman SM; Brinton EA; Clarkson T; Heward CB; Hecht HS; Karas RH; Judelson DR; Naftolin F
Endocrine; 2004 Aug; 24(3):195-202. PubMed ID: 15542885
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
11. Recent epidemiological evidence relevant to the clinical management of the menopause.
Shapiro S
Climacteric; 2007 Oct; 10 Suppl 2():2-15. PubMed ID: 17882666
[TBL] [Abstract][Full Text] [Related]
12. The relevance of the Women's Health Initiative results on combined hormone replacement therapy in clinical practice.
Lemay A
J Obstet Gynaecol Can; 2002 Sep; 24(9):711-5. PubMed ID: 12360366
[TBL] [Abstract][Full Text] [Related]
13. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
Chlebowski RT; Anderson GL; Aragaki AK; Prentice R
J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26546117
[TBL] [Abstract][Full Text] [Related]
16. Risk of cardiovascular disease in relation to the use of combined postmenopausal hormone therapy: detection bias and resolution of discrepant findings in two Women's Health Initiative studies.
Shapiro S
Climacteric; 2006 Dec; 9(6):416-20. PubMed ID: 17085373
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
F1000Res; 2019; 8():. PubMed ID: 31543950
[TBL] [Abstract][Full Text] [Related]
18. The Women's Health Initiative trials of menopausal hormone therapy: lessons learned.
Manson JE; Bassuk SS; Kaunitz AM; Pinkerton JV
Menopause; 2020 Aug; 27(8):918-928. PubMed ID: 32345788
[TBL] [Abstract][Full Text] [Related]
19. An update on hormone therapy in postmenopausal women: mini-review for the basic scientist.
Miller VM; Harman SM
Am J Physiol Heart Circ Physiol; 2017 Nov; 313(5):H1013-H1021. PubMed ID: 28801526
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
Burger H
Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
